Despite the fact that the orlistat (ORST) mechanism of action is through gastric/pancreatic lipase inhibition and its direct effect on adipocytes is equivocal [50], we have employed it as reference drug as it is approved and widely prescribed in anti-obesity therapeutic regimens [51]. Here, PNLIP is linked to obesity disorder.